(Q43247372)

17 November 2017

Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes (English)

1 reference

17 November 2017

0 references

1 reference

1 reference

Y F Dong

1

1 reference

17 November 2017

L Liu

2

1 reference

17 November 2017

K Kataoka

3

1 reference

17 November 2017

T Nakamura

4

1 reference

17 November 2017

M Fukuda

5

1 reference

17 November 2017

Y Tokutomi

6

1 reference

17 November 2017

H Nako

7

1 reference

17 November 2017

H Ogawa

8

1 reference

17 November 2017

S Kim-Mitsuyama

9

1 reference

17 November 2017

6 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

53

1 reference

17 November 2017

1

1 reference

17 November 2017

180-191

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1575-5

17 November 2017

0 references

cites work

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

1 reference

12 December 2020

Diabetes-obesity syndromes in mice

1 reference

12 December 2020

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis

1 reference

12 December 2020

Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

12 December 2020

Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

1 reference

12 December 2020

Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure

1 reference

12 December 2020

1 reference

12 December 2020

Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition

1 reference

12 December 2020

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes

1 reference

12 December 2020

Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.

1 reference

12 December 2020

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

12 December 2020

Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.

1 reference

12 December 2020

Biochemistry and molecular cell biology of diabetic complications

1 reference

12 December 2020

NAD(P)H oxidase: role in cardiovascular biology and disease

1 reference

12 December 2020

Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine

1 reference

12 December 2020

Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome

1 reference

12 December 2020

Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice

1 reference

12 December 2020

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

12 December 2020

Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats

1 reference

12 December 2020

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

1 reference

12 December 2020

Follow-up report on the diagnosis of diabetes mellitus

1 reference

12 December 2020

Diabetes and cardiovascular events in hypertensive patients

1 reference

12 December 2020

Aliskiren: the first renin inhibitor for clinical treatment

1 reference

12 December 2020

Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes

1 reference

12 December 2020

Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats

1 reference

12 December 2020

Oxidative stress as a major culprit in kidney disease in diabetes

1 reference

12 December 2020

Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat

1 reference

12 December 2020

Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis

1 reference

12 December 2020

Diabetic kidney disease in thedb/dbmouse

1 reference

12 December 2020

Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.

1 reference

12 December 2020

Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.

1 reference

12 December 2020

Role of oxidative stress in cardiac hypertrophy and remodeling

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist

1 reference

12 December 2020

Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure

1 reference

12 December 2020

Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.

1 reference

12 December 2020

10.1007/S00125-009-1575-5

Identifiers

DOI

1 reference

17 November 2017

1 reference